Navigation Links
AXA Equitable Makes it Easier to Stop Ignoring Life Insurance
Date:11/5/2007

Company Introduces Simplified Issue Underwriting for Return of Premium Term

NEW YORK, Nov. 5 /PRNewswire-FirstCall/ -- To make the purchase of life insurance easier and more convenient, AXA Equitable introduced today in approved states a simplified issue underwriting process for its Return of Premium Term (ROP Term(SM)) life insurance on policy face amounts from $100,000 to $249,999. "ROP Term with Simplified Issue makes buying life insurance easier and more convenient," said Claude Methot, Senior Vice President and Chief Product Officer, who made today's announcement. "There are no needles. No samples. No lengthy applications and complicated underwriting questionnaires. No paramed exams. No waiting for attending physician statements from your doctor." Instead, applying for ROP Term(SM) with Simplified Issue involves a painless, self-administered oral swab, a private 15 to 20 minute telephone interview, and a short application. Two underwriting classes are available - Simplified Issue Non-Tobacco User and Simplified Issue Tobacco User.

The Appeal of ROP Term(SM) - Protection and Refund Potential

AXA Equitable's ROP Term(SM) series offers level death protection for a selected period and the potential to receive a premium refund. If a policyholder outlives the ROP Term(SM) level premium period selected (20, 25 or 30 years) and the policy is still inforce, he or she will receive a refund of 100% of the eligible cumulative premiums paid*. The cash refunded is federal income tax free. "In essence," said Mr. Methot, "with ROP Term(SM) the policyholder gets the needed coverage during the level premium period, but if the insured lives beyond that period, she receives her money back. And now with simplified issue underwriting, we're making it easier to access these benefits."

Ease of Convertibility

As families and/or businesses grow, it may make sense to 'move up' to permanent life insurance, which offers lifelong death benefit protection. During specified periods, ROP Term(SM) Simplified Issue is convertible to AXA Equitable's permanent life insurance, without having to furnish additional evidence of insurability. No medical exams or blood tests are required.

Giving clients time to make up their mind, AXA Equitable's conversion privilege is available for the earlier of the first 15 years of a 20-year ROP Term(SM) policy, the first 17 years of a 25-year ROP Term(SM) policy and the first 20 years of a 30-year ROP Term(SM) policy, or until the policy anniversary nearest the insured's 70th birthday. When a policyholder exercises the conversion privilege, the cash value of the policy can be applied to the new permanent policy or, if preferred, taken in cash. In addition, AXA Equitable guarantees a conversion credit to reduce the first-year cost of the new permanent insurance policy

The Simplified Application Process - What to Expect

What Not to Expect What to Expect

Needles and blood Applicant self-administers a

painless oral swab collection

that takes two to five minutes.

The swab is then sent to an

independent lab for processing.

There's no need to abstain from

eating or drinking before the

test.

Scheduling a paramed exam A private, professional telephone

interviewer contacts the

applicant for a medical history

interview, lasting approximately

15 to 20 minutes (but may take

more or less time depending on

personal circumstances). The

interview is used to complete the

rest of the application.

Taking lots of time ROP Term(SM) Simplified Issue

underwriting uses a unique,

simplified application; a third-

party telephone interview and an

oral swab test. Because no

paramed or attending physician

statements are required, the

underwriting process results in

significant time savings.

AXA Equitable's Return of Premium Term(SM) (Policy forms 148-20, 148-25, 148-30 or state variations) is issued by and is a service mark of AXA Equitable Life Insurance Company, New York, NY. All guarantees are based on the claims-paying ability of AXA Equitable Life Insurance Company.

About AXA Equitable

AXA Equitable Life Insurance Company has been in business since 1859 and is a leading nationwide issuer of life insurance and annuity products. The company has over 11,000 employees and sales personnel and approximately 4.8 million policy/contract holders nationwide as of December 31, 2006. AXA Equitable Life Insurance Company, New York, N.Y., is one of the premier U.S. organizations providing life insurance and annuity products and services for the financial services market. Variable products are co-distributed by affiliates AXA Advisors, LLC, and AXA Distributors, LLC.

AXA Equitable's parent company, AXA Financial, Inc., is a member of the global AXA Group, a worldwide leader in financial protection and wealth management. AXA Group's operations are diverse geographically, with major operations in Western Europe, North America, and the Asia/Pacific region.

The AXA ordinary share is listed on the Paris Stock Exchange and trades under the symbol AXA. The AXA American Depositary Share is also listed on the NYSE under the ticker symbol AXA. AXA Equitable is solely responsible for its life insurance and annuity obligations.

AXA Equitable is a sponsor of the Variable Annuities Knowledge Center (http://www.variableannuityfacts.org), an online resource aimed at helping consumers understand the facts surrounding variable annuities. The Variable Annuities Knowledge Center is operated by a standalone non-profit organization and is overseen by an independent advisory board.

* Eligible cumulative premiums include premiums for the policy that were paid prior to the benefits expiration date and do not include premiums for riders or additional risks. Eligible cumulative premiums are also reduced by any outstanding policy loans.


'/>"/>
SOURCE AXA Equitable
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. AXA Equitable Life Insurance Co. Hires William McDermott to Lead Corporate Retirement Planning Business
2. David Kahal Joins AXA Equitable as National Sales Manager
3. San Francisco Bay Area Autism Speaks Chapter Endorses Blue Ribbon Commission on Autism Recommendations for Equitable Insurance Coverage for Children With Autism
4. New Smart Technology Makes Patient Data Collection Easier, More Efficient
5. WeissComm Partners Makes 10 New Hires as It Wins New Accounts and Grows Existing Business
6. Independence Blue Cross Makes Music for Members Ears
7. A Place for Mom COO Makes Seattles 40 Under 40 List
8. Sesame Street Exhibition Makes Texas Premier at The Health Museum
9. Study makes progress in zoning in on biomarkers for better colon cancer treatment
10. New Online Tool Makes Enrollment in Blue Cross of California Easier
11. 1-800-PACK-RAT Makes a Splash During Annual Walk for Hope
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... ... blend of L-Citrulline and glutathione to enhance production of nitric oxide (NO). , ... have shown to produce NO twice as effectively and sustains NO blood levels ...
(Date:12/5/2016)... Fla (PRWEB) , ... December 05, 2016 , ... ... as Keynote speaker for the 21st Annual International Congress on Hematologic Malignancies®: Focus ... announcement, PER® president, Phil Talamo said, “We are honored to have Amy E. ...
(Date:12/5/2016)... (PRWEB) , ... December 05, ... ... strategic interoperability, today announced that the company will provide alerting technology to ... has been recently awarded $1.7 million in federal funds as the sole ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... geographic lines. The goal of Castlewood Treatment Centers has always been to promote ... to as many people as possible. In that spirit, Castlewood has announced two ...
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... BSI and ... the United States and Canada for distribution of their natural fruits and beverage ... line is an exciting addition to our Life Sciences product portfolio,” said Steve ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... According to a new market research report ... Factor Technology, Tissue Scaffolds, Cell-free composites), Application (Hyaline Cartilage, Fibrocartilage), by ... projected to reach USD 779.8 Million by 2021 from USD 414.6 ... forecast period of 2016 to 2021. ... ...
(Date:12/5/2016)... 5, 2016  Sharn Anesthesia Inc. announced today that ... distribution partner for Salter Labs.  The company also received ... recognition of outstanding sales performance. Salter Labs ... anesthesia care, including the market gold standard ECO 2 ... distributor of the Parker Flex-Tip® Endotracheal Tube, which is ...
(Date:12/5/2016)... and PUNE, India , December 5, 2016 /PRNewswire/ ... titled, "Surgical Sutures Market by Product Type and by Application - Global Opportunity ... for $3,360 million in 2015, and is expected to reach $5,255 million by ... segment dominated the market in 2015 with more than four-fifths share. ... ...
Breaking Medicine Technology: